The Situation
Small-cap biotech company (NASDAQ), $40M market cap, filed the 10-K on time.
Three weeks later: an SEC comment letter. 15 comments across revenue recognition, clinical trial accounting, and going concern disclosure.
CEO's reaction: Panic. CFO's reaction: "We have 10 business days to respond. I don't even understand half these comments."
What Most Would Do
Panic. Call the lawyers. Write defensive responses. Miss the deadline.
The Unfolding Values Analysis
SEC comment letters are not enforcement actions. They're questions.
Day 1 diagnostic: categorized all 15 comments.
- Category A (8 comments): Clarification requests; answer immediately
- Category B (5 comments): Disclosure expansion; straightforward
- Category C (2 comments): Accounting position challenges; requires technical analysis
- Category D (0 comments): Potential restatement; none
Real timeline: 7 days for A+B, 20 days for C. Doable.
The Decision Tree
Option A: Request a 30-day extension. More time but signals weakness, extends uncertainty.
Option B: Rush the response in 10 days. Shows responsiveness but quality suffers.
Option C: Targeted response (Recommended). 7 days for simple comments, 20 days for complex ones. Shows capability without sacrificing quality.
The Outcome
- First batch of 13 responses submitted in 7 days
- Final 2 responses submitted in 21 days
- Follow-up: 2 minor clarifications (answered in 3 days)
- Total exchange: 2 rounds (most companies go 3-4)
- Stock impact: Zero
- Outcome: Comment letter closed, no further action
Key Principles
- SEC comment letters are routine, not crises. How you respond determines the outcome.
- Categorization matters. Don't treat every comment the same. Easy stuff fast, hard stuff right.
- Coordinate with auditors early. If they signed off on the accounting, they should support the response.
This is general guidance, not advice on your facts. Unfolding Values is not an audit firm and does not provide attest services. For a read on your specific situation, reach out.
Before the next filing goes out: put a senior second set of eyes on it with the Pre-Filing QC Review, from $1,500 fixed.
From the Filing Seat
Get the monthly From the Filing Seat note: one practical SEC/GAAP insight from the filing seat. No spam.